Literature DB >> 26794004

The role of microRNA in esophageal squamous cell carcinoma.

Kazuto Harada1, Yoshifumi Baba1, Takatsugu Ishimoto1, Hironobu Shigaki1, Keisuke Kosumi1, Naoya Yoshida1, Masayuki Watanabe2, Hideo Baba3.   

Abstract

MicroRNAs (miRNA) are 22-nucleotide non-coding RNAs that post-transcriptionally regulate gene expression by base pairing to partially complementary sequences in the 3'-untranslated region of their target messenger RNA. Altered miRNA expression also changes the expression of oncogenes and tumor suppressors, affecting the proliferation, apoptosis, motility and invasibility of gastrointestinal cancer cells, including the cells of esophageal squamous cell carcinoma (ESCC). It has been suggested that various miRNA expression profiles may provide useful biomarkers and therapeutic targets, but to date few studies have been published on the role of miRNA in ESCC. In this review we summarize the identification and characterization of miRNAs involved in ESCC and discuss their potential as biomarkers and therapeutic targets.

Entities:  

Keywords:  Biomarkers; Esophageal squamous cell carcinoma; MicroRNA; Review; Therapeutic targets

Mesh：

Substances：

Year:  2016        PMID： 26794004     DOI： 10.1007/s00535-016-1161-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


  110 in total

1.  TNF-α is a novel target of miR-19a.

Authors:  Mei Liu; Zaozao Wang; Shangbin Yang; Wei Zhang; Shun He; Chenfei Hu; Hongxia Zhu; Lanping Quan; Jinfeng Bai; Ningzhi Xu
Journal:  Int J Oncol       Date:  2011-01-25       Impact factor: 5.650

Review 2.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

Review 3.  How microRNAs control cell division, differentiation and death.

Authors:  Eric A Miska
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

4.  Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.

Authors:  Koji Tanaka; Hiroshi Miyata; Makoto Yamasaki; Keijiro Sugimura; Tsuyoshi Takahashi; Yukinori Kurokawa; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Ann Surg Oncol       Date:  2013-07-10       Impact factor: 5.344

5.  Down-Regulation of MiR-1294 is Related to Dismal Prognosis of Patients with Esophageal Squamous Cell Carcinoma through Elevating C-MYC Expression.

Authors:  Kai Liu; Liyi Li; Aizemaiti Rusidanmu; Yongqing Wang; Xiayi Lv
Journal:  Cell Physiol Biochem       Date:  2015-04-27

6.  miR-29b inhibits the progression of esophageal squamous cell carcinoma by targeting MMP-2.

Authors:  Y Qi; X Li; S Zhao
Journal:  Neoplasma       Date:  2015       Impact factor: 2.575

7.  MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.

Authors:  Xiaohui Xu; Zhaoli Chen; Xiaohong Zhao; Jiwen Wang; Dapeng Ding; Zhen Wang; Fengwei Tan; Xiaogang Tan; Fang Zhou; Jian Sun; Nan Sun; Yibo Gao; Kang Shao; Ning Li; Bin Qiu; Jie He
Journal:  Biochem Biophys Res Commun       Date:  2012-03-17       Impact factor: 3.575

8.  Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.

Authors:  Rie Hamano; Hiroshi Miyata; Makoto Yamasaki; Yukinori Kurokawa; Johji Hara; Jeong Ho Moon; Kiyokazu Nakajima; Shuji Takiguchi; Yoshiyuki Fujiwara; Masaki Mori; Yuichiro Doki
Journal:  Clin Cancer Res       Date:  2011-01-19       Impact factor: 12.531

9.  Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.

Authors:  Miao Yang; Ran Liu; Jingyi Sheng; Juan Liao; Yi Wang; Enchun Pan; Wei Guo; Yuepu Pu; Lihong Yin
Journal:  Oncol Rep       Date:  2012-10-23       Impact factor: 3.906

10.  Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma.

Authors:  Heping Li; Dayong Zheng; Bing Zhang; Liangshuai Liu; Junwei Ou; Wei Chen; Shiqiu Xiong; Yong Gu; Jianyong Yang
Journal:  J Transl Med       Date:  2014-07-15       Impact factor: 5.531
View more
  26 in total

1.  MicroRNAs are novel non-invasive diagnostic biomarkers for pulmonary embolism: a meta-analysis.

Authors:  Han-Yu Deng; Gang Li; Jun Luo; Zhi-Qiang Wang; Xiao-Yan Yang; Yi-Dan Lin; Lun-Xu Liu
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  miR-25 is upregulated before the occurrence of esophageal squamous cell carcinoma.

Authors:  Yaxu Jia; Heng Lu; Cheng Wang; Junjun Wang; Chenyu Zhang; Fangyu Wang; Chunni Zhang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

3.  miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma.

Authors:  Jianfeng Xu; Haiyan Lv; Bo Zhang; Feng Xu; Hongyu Zhu; Baofu Chen; Chengchu Zhu; Jianfei Shen
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

4.  circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway.

Authors:  Shifan Zhou; Zhizhong Guo; Chaofeng Zhou; Yu Zhang; Sai Wang
Journal:  Cancer Cell Int       Date:  2021-05-06       Impact factor: 5.722

Review 5.  The predictive value of microRNAs for pathological response after neoadjuvant treatment in esophageal squamous cell carcinoma: a systematic review.

Authors:  Dong Lin; Xiaosang Chen; Lijie Tan
Journal:  Ann Transl Med       Date:  2021-03

6.  Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.

Authors:  Yusaku Osako; Naohiko Seki; Yoshiaki Kita; Keiichi Yonemori; Keiichi Koshizuka; Akira Kurozumi; Itaru Omoto; Ken Sasaki; Yasuto Uchikado; Hiroshi Kurahara; Kosei Maemura; Shoji Natsugoe
Journal:  Int J Oncol       Date:  2016-10-21       Impact factor: 5.650

Review 7.  Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer.

Authors:  Xiaobin Hou; Jiaxin Wen; Zhipeng Ren; Guoliang Zhang
Journal:  Oncotarget       Date:  2017-06-27

8.  KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progression.

Authors:  Yuji Fujita; Kiyoshi Masuda; Junichi Hamada; Katsutoshi Shoda; Takuya Naruto; Satoshi Hamada; Yuko Miyakami; Tomohiro Kohmoto; Miki Watanabe; Rizu Takahashi; Shoichiro Tange; Masako Saito; Yasusei Kudo; Hitoshi Fujiwara; Daisuke Ichikawa; Akira Tangoku; Eigo Otsuji; Issei Imoto
Journal:  Oncotarget       Date:  2017-09-15

9.  An esophageal squamous cell carcinoma classification system that reveals potential targets for therapy.

Authors:  Teng Xiong; Mengyao Wang; Jing Zhao; Qing Liu; Chao Yang; Wen Luo; Xiangchun Li; Huanming Yang; Karsten Kristiansen; Bhaskar Roy; Yong Zhou
Journal:  Oncotarget       Date:  2017-07-25

10.  Downregulation of microRNA‑449a‑5p promotes esophageal squamous cell carcinoma cell proliferation via cyclin D1 regulation.

Authors:  Tao Jiang; Junfeng Liu; Jixing Mu
Journal:  Mol Med Rep       Date:  2018-05-17       Impact factor: 2.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.